8-K: NRC Health Reports Lower Q3 Revenue and Earnings, Returns Capital to Shareholders

NRC Health announced a decrease in revenue and earnings per share for the third quarter of 2024, while returning capital to shareholders through dividends and stock repurchases.

Summary

• National Research Corporation, operating as NRC Health, released its financial results for the third quarter of 2024.
• The company's revenue for the quarter was approximately $35.8 million, down from $37.9 million in the same quarter of 2023.
• Earnings per diluted share decreased to $0.24, compared to $0.32 in the third quarter of the previous year.
• Net indebtedness stood at approximately $50.2 million as of September 30, 2024.
• Total recurring contract value (TRCV) was approximately $131.6 million at the end of the quarter.
• NRC Health returned approximately $11.5 million to stockholders through dividends and stock repurchases during the quarter.
• The company repurchased approximately 395,000 shares for about $8.6 million and paid a regular quarterly dividend of $0.12 per share, totaling approximately $2.9 million.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the decrease in revenue and earnings, although the company is returning capital to shareholders. The forward-looking statements are cautious, and the overall tone suggests some challenges.

Positives

• The company returned a significant amount of capital, approximately $11.5 million, to shareholders through dividends and stock repurchases.
• The company maintained a regular quarterly dividend of $0.12 per share.
• Total recurring contract value (TRCV) remains strong at approximately $131.6 million.

Negatives

• Revenue decreased to $35.8 million from $37.9 million compared to the same quarter last year.
• Earnings per diluted share decreased to $0.24 from $0.32 compared to the same quarter last year.
• Net indebtedness is approximately $50.2 million.

Risks

• The company's financial results are subject to risks and uncertainties, as detailed in their annual report and other filings.
• Forward-looking statements are based on current beliefs and expectations and are subject to change.
• Actual results may differ materially from those anticipated in forward-looking statements.

Future Outlook

The company has declared a future quarterly cash dividend of $0.12 per share, payable on January 10, 2025, to stockholders of record as of December 27, 2024. The company disclaims any obligation to update or revise any forward-looking statements.

Management Comments

• The company's management believes that the statements in the press release are forward-looking and subject to risks and uncertainties.
• Management has stated that actual results may differ from those anticipated in forward-looking statements.

Industry Context

NRC Health operates in the healthcare market research and patient experience sector. The results reflect the challenges and trends in the healthcare industry, including potential shifts in client spending and market dynamics.

Comparison to Industry Standards

• The decrease in revenue and earnings per share is a concern, as many companies in the healthcare technology and services sector are experiencing growth.
• Companies like Press Ganey and Medallia, which also focus on patient experience and healthcare analytics, have shown varying results, making it important to compare NRC Health's performance against these specific competitors.
• The total recurring contract value (TRCV) of $131.6 million is a positive indicator, but it needs to be compared to the TRCV growth of similar companies to assess its relative strength.

Stakeholder Impact

• Shareholders will be impacted by the decreased earnings per share, but also by the return of capital through dividends and stock repurchases.
• Employees may be affected by the company's overall financial performance.
• Customers may be impacted by any changes in the company's services or offerings.

Next Steps

• The company will pay a quarterly dividend on January 10, 2025.
• The company will continue to monitor and report on its financial performance.

Key Dates

Keywords

financial results, quarterly earnings, revenue, earnings per share, dividends, stock repurchases, net indebtedness, TRCV, healthcare, market research